ICD-10 Specific code B25: Cytomegaloviral disease
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Cytomegaloviral disease |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | I | Certain infectious and parasitic diseases | |
| 2 | B25-B34 | Other viral diseases | |
| 3 | B25 | Cytomegaloviral disease |
Contents
| Code | Title | |
|---|---|---|
| B25.0 | Cytomegaloviral pneumonitis | |
| B25.1 | Cytomegaloviral hepatitis | |
| B25.2 | Cytomegaloviral pancreatitis | |
| B25.8 | Other cytomegaloviral diseases | |
| B25.9 | Cytomegaloviral disease, unspecified |
Indicated medicines
| Active Ingredient |
|---|
|
Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines. |
|
Valaciclovir, an antiviral, is the L-valine ester of aciclovir. Valaciclovir is rapidly and almost completely converted in man to aciclovir and valine. Aciclovir is a specific inhibitor of the herpes viruses with in vitro activity against herpes simplex viruses (HSV) type 1 and type 2, varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr Virus (EBV), and human herpes virus 6 (HHV-6). |